Very recently, a prospective small pilot study evaluated the impact of 24-week high-dose oral vitamin D supplementation on liver histology of 12 non-cirrhotic NASH patients, finding no beneficial effects of this treatment on hepatic damage or insulin sensitivity [29]; however, vitamin D effects on hepatic fat content in NAFLD have never been tested. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.